These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33460401)

  • 1. Systems pharmacology dissection of
    Huang C; Li Z; Zhu J; Chen X; Hao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
    Aging (Albany NY); 2021 Jan; 13(2):2912-2940. PubMed ID: 33460401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective.
    Xiao Y; Zhang L; Zhu J; Zhang Y; Yang R; Yan J; Huang R; Zheng C; Xiao W; Huang C; Wang Y
    Biomed Pharmacother; 2021 Nov; 143():112105. PubMed ID: 34560533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems pharmacology: a combination strategy for improving efficacy of PD-1/PD-L1 blockade.
    Zheng C; Xiao Y; Chen C; Zhu J; Yang R; Yan J; Huang R; Xiao W; Wang Y; Huang C
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33876189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
    Song J; Feng L; Zhong R; Xia Z; Zhang L; Cui L; Yan H; Jia X; Zhang Z
    Mol Carcinog; 2017 Jan; 56(1):36-48. PubMed ID: 26859114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharides from Epimedium koreanum Nakai with immunomodulatory activity and inhibitory effect on tumor growth in LLC-bearing mice.
    Wang C; Feng L; Su J; Cui L; Dan Liu ; Yan J; Ding C; Tan X; Jia X
    J Ethnopharmacol; 2017 Jul; 207():8-18. PubMed ID: 28627460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment.
    Iwahori K; Shintani Y; Funaki S; Yamamoto Y; Matsumoto M; Yoshida T; Morimoto-Okazawa A; Kawashima A; Sato E; Gottschalk S; Okumura M; Kumanogoh A; Wada H
    Sci Rep; 2019 Feb; 9(1):2636. PubMed ID: 30796310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol treatment inhibits abnormal tumor growth by regulating neutrophil infiltration in a non-small cell lung carcinoma mouse model.
    Kim G; Kim EY; Lee H; Shin SH; Lee SH; Sohn KY; Kim JW; Lee JS
    Biomed Pharmacother; 2024 Sep; 178():117269. PubMed ID: 39137654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer.
    Zhang M; Yang W; Wang P; Deng Y; Dong YT; Liu FF; Huang R; Zhang P; Duan YQ; Liu XD; Lin D; Chu Q; Zhong B
    Nat Commun; 2020 Nov; 11(1):6119. PubMed ID: 33257678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
    Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
    Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape.
    Takeuchi Y; Tanegashima T; Sato E; Irie T; Sai A; Itahashi K; Kumagai S; Tada Y; Togashi Y; Koyama S; Akbay EA; Karasaki T; Kataoka K; Funaki S; Shintani Y; Nagatomo I; Kida H; Ishii G; Miyoshi T; Aokage K; Kakimi K; Ogawa S; Okumura M; Eto M; Kumanogoh A; Tsuboi M; Nishikawa H
    Sci Immunol; 2021 Nov; 6(65):eabc6424. PubMed ID: 34767457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAML promotes the antitumor role of tumor-resident CD8
    Hao Z; Xin Z; Chen Y; Shao Z; Lin W; Wu W; Lin M; Liu Q; Chen D; Wu D; Wu P
    Cancer Lett; 2024 May; 590():216839. PubMed ID: 38570084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-cell-secreted CXCL11 promoted CD8
    Gao Q; Wang S; Chen X; Cheng S; Zhang Z; Li F; Huang L; Yang Y; Zhou B; Yue D; Wang D; Cao L; Maimela NR; Zhang B; Yu J; Wang L; Zhang Y
    J Immunother Cancer; 2019 Feb; 7(1):42. PubMed ID: 30744691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.